Tarsus Pharmaceuticals, Inc. (TARS)
72.10
-0.71
(-0.98%)
USD |
NASDAQ |
Aug 25, 13:43
Tarsus Pharmaceuticals 1 Year Total Returns (Daily) : 27.18% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 27.18% |
| August 21, 2026 | 28.54% |
| August 20, 2026 | 29.02% |
| August 19, 2026 | 36.76% |
| August 18, 2026 | 30.07% |
| August 17, 2026 | 30.26% |
| August 14, 2026 | 27.82% |
| August 13, 2026 | 30.65% |
| August 12, 2026 | 36.32% |
| August 11, 2026 | 38.73% |
| August 10, 2026 | 41.61% |
| August 07, 2026 | 35.12% |
| August 06, 2026 | 56.89% |
| August 05, 2026 | 48.94% |
| August 04, 2026 | 45.81% |
| August 03, 2026 | 50.26% |
| July 31, 2026 | 52.09% |
| July 30, 2026 | 48.85% |
| July 29, 2026 | 45.79% |
| July 28, 2026 | 41.20% |
| July 27, 2026 | 44.87% |
| July 24, 2026 | 38.22% |
| July 23, 2026 | 38.75% |
| July 22, 2026 | 35.99% |
| July 21, 2026 | 35.75% |
| Date | Value |
|---|---|
| July 20, 2026 | 30.06% |
| July 17, 2026 | 44.57% |
| July 16, 2026 | 38.84% |
| July 15, 2026 | 41.70% |
| July 14, 2026 | 35.11% |
| July 13, 2026 | 51.38% |
| July 10, 2026 | 41.25% |
| July 09, 2026 | 55.34% |
| July 08, 2026 | 70.65% |
| July 07, 2026 | 76.68% |
| July 06, 2026 | 62.94% |
| July 02, 2026 | 61.78% |
| July 01, 2026 | 52.26% |
| June 30, 2026 | 55.37% |
| June 29, 2026 | 51.82% |
| June 26, 2026 | 56.01% |
| June 25, 2026 | 60.05% |
| June 24, 2026 | 62.10% |
| June 23, 2026 | 62.98% |
| June 22, 2026 | 56.36% |
| June 18, 2026 | 53.79% |
| June 17, 2026 | 58.68% |
| June 16, 2026 | 47.25% |
| June 15, 2026 | 51.26% |
| June 12, 2026 | 51.28% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Structure Therapeutics, Inc. | 149.9% |
| Alumis, Inc. | 375.8% |
| Veradermics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | -18.50% |
| Corcept Therapeutics, Inc. | 75.23% |